ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,597.55
1.13%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Pluristem Therapeutics Inc (PSTI)

  7. Pluristem Therapeutics Inc (PSTI) ニュース

PSTI

Pluristem Therapeutics (PSTI)

Pluristem Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PSTI
日付受信時刻ニュースソース見出しコード企業名
2023/06/0919 : 04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PSTIPluristem Therapeutics Inc
2023/06/0205 : 06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PSTIPluristem Therapeutics Inc
2023/05/1005 : 17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
2023/04/2605 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2023/02/2721 : 58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PSTIPluristem Therapeutics Inc
2023/02/2721 : 53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PSTIPluristem Therapeutics Inc
2023/02/1622 : 59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PSTIPluristem Therapeutics Inc
2023/02/1622 : 17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSTIPluristem Therapeutics Inc
2023/02/1420 : 27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PSTIPluristem Therapeutics Inc
2023/02/1406 : 39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PSTIPluristem Therapeutics Inc
2023/02/0623 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2023/01/2506 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/12/2906 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/12/2222 : 55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSTIPluristem Therapeutics Inc
2022/12/2006 : 14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/11/1106 : 01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
2022/10/1405 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/09/2923 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/09/2206 : 17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PSTIPluristem Therapeutics Inc
2022/09/2205 : 03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/07/2522 : 39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/07/2520 : 00GlobeNewswire Inc.Pluri CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
2022/07/2514 : 00GlobeNewswire Inc.Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional IndustriesNASDAQ:PSTIPluristem Therapeutics Inc
2022/07/1721 : 20TipRanksPluristem (PSTI) Receives a Buy from H.C. WainwrightNASDAQ:PSTIPluristem Therapeutics Inc
2022/07/1322 : 29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/07/1319 : 00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
2022/06/2405 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
2022/05/1521 : 25TipRanksDawson James Thinks Pluristem’s Stock is Going to RecoverNASDAQ:PSTIPluristem Therapeutics Inc
2022/03/2816 : 00GlobeNewswire Inc.Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New PartnershipNASDAQ:PSTIPluristem Therapeutics Inc
2022/03/2320 : 30GlobeNewswire Inc.Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood TransfusionsNASDAQ:PSTIPluristem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTI

最近閲覧した銘柄

NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
NYSE
BAC
Bank of America
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AAPL
Apple
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有